Global Endocrine, Nutritional and Metabolic Diseases Mortality by Country

The mortality rates for endocrine, nutritional, and metabolic diseases vary significantly across countries. In 2023, Mexico reported the highest death toll at 152.51 thousand, while Iceland had the lowest at 0.055 thousand. Countries like Costa Rica and Estonia saw significant year-on-year increases, at 21.09% and 18.03%, respectively. In contrast, Slovakia experienced a decline of 2.56%. Over the past five years, these rates have shown varying degrees of increase, with factors such as healthcare advancements and public health initiatives influencing trends.

Future trends to watch include the impact of improved healthcare systems and policies aimed at prevention and management. There is an expected continuation of declining rates in developed countries, while emerging economies might see fluctuating trends due to economic and healthcare system variables.

Top countries in Endocrine, Nutritional and Metabolic Diseases Mortality by Country

# 10 Countries Units (Deaths) Last Year YoY 5-years CAGR
1 1 Mexico 152,510 2023 +3.7% +5.91% View data
2 2 Brazil 98,410 2023 +2.02% +3.88% View data
3 3 Germany 37,300 2023 +0.91% +1.49% View data
4 4 South Africa 35,230 2023 +1.32% +1.43% View data
5 5 Japan 22,990 2023 +0.77% +0.31% View data
6 6 Colombia 17,260 2023 +6.59% +10.45% View data
7 7 Spain 15,320 2023 +0.63% +2.62% View data
8 8 Peru 14,040 2023 +9.75% +12.24% View data
9 9 Poland 13,980 2023 +2.54% +7.71% View data
10 10 Argentina 13,290 2023 +1.14% +1.32% View data

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease